GLYC Insider Trading - GlycoMimetics, Inc.

Saham Orang Dalam

4,186,375 shares

Skor Sentimen Orang Dalam

Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.

Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan akumulasi orang dalam tertinggi.

Lihat Saham dengan Peringkat Tertinggi

Skor Sentimen Petugas

Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.

Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.

Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan sentimen orang dalam tertinggi.

Lihat Saham dengan Peringkat Tertinggi

Metrik Utama Orang Dalam

Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.

Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).

Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)

N/A

Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).

Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)

N/A

Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.

Grafik Perdagangan Orang Dalam

Grafik berikut menunjukkan GlycoMimetics, Inc. transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.

Daftar Orang Dalam dan Metrik Profitabilitas

Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.

See our leaderboard of most profitable insider traders.

Orang Dalam	Rata-rata Keuntungan (%)	Saham Dimiliki	Terbagi Disesuaikan

Report errors via our new Insider Auditing Tool

Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di GLYC / GlycoMimetics, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan	Orang Dalam	Dilaporkan Saham	Dilaporkan Harga	Disesuaikan Saham	Disesuaikan Harga	Dasar Biaya	Hari-hari menuju Maksimal	Harga di Maksimal	Maksimal Keuntungan ($)	Maksimum Pengembalian (%)
2024-06-21	Rock Edwin	115,000	0.2671	1,150	26.7100	30,716	130	0.4900	-30,152	-98.17
2024-06-20	Rock Edwin	190,000	0.2532	1,900	25.3200	48,108
2024-06-18	Hahn Brian M.	17,500	0.2477	175	24.7700	4,335
2023-09-22	Rock Edwin	30,403	1.3800	304	138.0000	41,956
2023-09-21	Rock Edwin	35,000	1.3800	350	138.0000	48,300
2023-05-10	JUNIUS DANIEL M	30,000	1.5600	300	156.0000	46,800
2023-05-08	Johnson Bruce S	13,500	1.5700	135	157.0000	21,195
2023-02-24	Invus Public Equities, L.P.	100,000	1.7000	1,000	170.0000	170,000
2023-02-23	Invus Public Equities, L.P.	200,000	1.7538	2,000	175.3800	350,760

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

GLYC / GlycoMimetics, Inc. Insider Trades

Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek

Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di GLYC / GlycoMimetics, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan	Orang Dalam	Dilaporkan Saham	Dilaporkan Harga	Disesuaikan Saham	Disesuaikan Harga	Dasar Biaya	Hari-hari menuju Menit	Harga di Menit	Kerugian Maksimal Dihindari ($)	Kerugian Maksimal Dihindari (%)
2024-08-08	Invus Public Equities, L.P.	260,873	0.1917	2,609	19.1700	50,009	62	0.1435	-49,635	-99.25
2024-08-07	Invus Public Equities, L.P.	61,488	0.1821	615	18.2100	11,197
2024-08-06	Invus Public Equities, L.P.	55,732	0.1828	557	18.2800	10,188
2024-08-05	Invus Public Equities, L.P.	164,523	0.1884	1,645	18.8400	30,996
2024-08-02	Invus Public Equities, L.P.	286,200	0.2004	2,862	20.0400	57,354
2024-08-01	Invus Public Equities, L.P.	63,564	0.2162	636	21.6200	13,743
2024-07-30	Invus Public Equities, L.P.	756,835	0.2209	7,568	22.0900	167,185
2024-07-29	Invus Public Equities, L.P.	363,949	0.2353	3,639	23.5300	85,637
2024-07-26	Invus Public Equities, L.P.	258,335	0.2417	2,583	24.1700	62,440

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

Riwayat Transaksi

Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.

Berkas Tanggal	Perdagangan Tanggal	Formulir	Orang Dalam	Ticker	Judul Keamanan	Kode	Langsung	Latihan Harga	Satuan Harga	Unit Diubah	Nilai Diubah (1 ribu)	Sisa Pilihan	Sisa Saham
2025-06-23		3	Doughty Christopher Grant	CBIO	Ordinary Shares		D						39,480
2025-06-23		3	Brumm Joshua T	CBIO	Ordinary Shares		D						268,400
2025-06-23		3	McNeill Jonathan	CBIO	Ordinary Shares		D						134,200
2025-06-23		3	Fairmount Funds Management LLC By Fairmount Healthcare Fund II L.P.	CBIO	Ordinary Shares		I						1,387,866
2025-06-23		3	Violin Jonathan	CBIO	Ordinary Shares		D						69,515
2025-06-17	2025-06-13	4	BVF PARTNERS L P/IL	CBIO	Common Stock	J - Other	D			56,079			62,383
2025-06-17	2025-06-13	4	BVF PARTNERS L P/IL	CBIO	Common Stock	J - Other	D			556,617			593,740
2025-06-17	2025-06-13	4	BVF PARTNERS L P/IL	CBIO	Common Stock	J - Other	D			657,308			707,116
2024-08-09	2024-08-08	4	Invus Public Equities, L.P.	GLYC	Common Stock	S - Sale	D		0.1917	-260,873	-50		6,317,565
2024-08-09	2024-08-07	4	Invus Public Equities, L.P.	GLYC	Common Stock	S - Sale	D		0.1821	-61,488	-11		6,578,438
2024-08-07	2024-08-06	4	Invus Public Equities, L.P.	GLYC	Common Stock	S - Sale	D		0.1828	-55,732	-10		6,639,926
2024-08-07	2024-08-05	4	Invus Public Equities, L.P.	GLYC	Common Stock	S - Sale	D		0.1884	-164,523	-31		6,695,658
2024-08-05	2024-08-02	4	Invus Public Equities, L.P.	GLYC	Common Stock	S - Sale	D		0.2004	-286,200	-57		6,860,181
2024-08-05	2024-08-01	4	Invus Public Equities, L.P.	GLYC	Common Stock	S - Sale	D		0.2162	-63,564	-14		7,146,381
2024-07-30	2024-07-30	4	Invus Public Equities, L.P.	GLYC	Common Stock	S - Sale	D		0.2209	-756,835	-167		7,209,945
2024-07-30	2024-07-29	4	Invus Public Equities, L.P.	GLYC	Common Stock	S - Sale	D		0.2353	-363,949	-86		7,966,780
2024-07-30	2024-07-26	4	Invus Public Equities, L.P.	GLYC	Common Stock	S - Sale	D		0.2417	-258,335	-62		8,330,729
2024-07-29		3	Siren, L.L.C.	GLYC	Common Stock		D						8,589,064
2024-06-24	2024-06-21	4	Rock Edwin	GLYC	Common Stock	P - Purchase	D		0.2671	115,000	31		680,403
2024-06-24	2024-06-20	4	Rock Edwin	GLYC	Common Stock	P - Purchase	D		0.2532	190,000	48		565,403
2024-06-20	2024-06-18	4	Hahn Brian M.	GLYC	Common Stock	P - Purchase	D		0.2477	17,500	4		70,643
2024-04-02	2024-03-29	4	Goldberg Mark Alan	GLYC	Common Stock	A - Award	D		3.0000	4,584	14		24,828
2024-04-02	2024-03-29	4	JUNIUS DANIEL M	GLYC	Common Stock	A - Award	D		3.0000	5,209	16		98,459
2024-04-02	2024-03-29	4	King Rachel K.	GLYC	Common Stock	A - Award	D		3.0000	3,334	10		515,194
2024-01-02	2023-12-29	4	Goldberg Mark Alan	GLYC	Common stock	A - Award	D		2.3600	5,827	14		20,244
2024-01-02	2023-12-29	4	King Rachel K.	GLYC	Common stock	A - Award	D		2.3600	4,238	10		511,860
2024-01-02	2023-12-29	4	Andrews Patricia S	GLYC	Common stock	A - Award	D		2.3600	5,191	12		58,608
2023-10-03	2023-09-30	4	Goldberg Mark Alan	GLYC	Common stock	A - Award	D		1.5000	9,167	14		14,417
2023-10-03	2023-09-30	4	King Rachel K.	GLYC	Common stock	A - Award	D		1.5000	6,667	10		507,622
2023-10-03	2023-09-30	4	Andrews Patricia S	GLYC	Common stock	A - Award	D		1.5000	8,167	12		53,417
2023-09-25	2023-09-22	4	Rock Edwin	GLYC	Common Stock	P - Purchase	D		1.3800	30,403	42		375,403
2023-09-25	2023-09-21	4	Rock Edwin	GLYC	Common Stock	P - Purchase	D		1.3800	35,000	48		345,000
2023-06-02	2023-06-01	4	Koenig Scott	GLYC	Common Stock	M - Exercise	D		0.6000	21,000	13		36,750
2023-05-18	2023-05-17	4	Hahn Brian M.	GLYC	Common Stock	S - Sale	D		1.9500	-3,700	-7		53,143
2023-05-11	2023-05-10	4	JUNIUS DANIEL M	GLYC	Common Stock	P - Purchase	D		1.5600	30,000	47		93,250
2023-05-09	2023-05-08	4	Johnson Bruce S	GLYC	Common Stock	P - Purchase	D		1.5700	13,500	21		138,980
2023-03-31		3	Rath Chinmaya	GLYC	Common Stock		D						161,178
2023-03-31		3	Johnson Bruce S	GLYC	Common Stock		D						125,480
2023-02-28	2023-02-24	4	Invus Public Equities, L.P.	GLYC	Common Stock	P - Purchase	D		1.7000	100,000	170		8,589,064
2023-02-23	2023-02-23	4	Invus Public Equities, L.P.	GLYC	Common Stock	P - Purchase	D		1.7538	200,000	351		8,489,064
2023-02-23	2023-02-22	4	Invus Public Equities, L.P.	GLYC	Common Stock	P - Purchase	D		1.7933	150,000	269		8,289,064
2023-02-23	2023-02-21	4	Invus Public Equities, L.P.	GLYC	Common Stock	P - Purchase	D		1.8500	50,000	92		8,139,064
2023-02-17	2023-02-17	4	Invus Public Equities, L.P.	GLYC	Common Stock	P - Purchase	D		1.7050	200,000	341		8,089,064
2023-02-17	2023-02-16	4	Invus Public Equities, L.P.	GLYC	Common Stock	P - Purchase	D		1.6847	315,266	531		7,889,064
2023-02-17	2023-02-15	4	Invus Public Equities, L.P.	GLYC	Common Stock	P - Purchase	D		2.1558	1,000,000	2,156		7,573,798
2023-02-13	2023-02-09	4	Invus Public Equities, L.P.	GLYC	Common Stock	P - Purchase	D		3.2419	11,451	37		6,573,798
2023-02-13		3	Invus Public Equities Advisors, LLC	GLYC	Common Stock		D						6,562,347
2023-02-06	2022-08-02	5	King Rachel K. By RBK LLC	GLYC	Common Stock	W - Other	I			7,500			7,500
2023-02-06	2022-02-15	5	King Rachel K.	GLYC	Common Stock	W - Other	D			11,641			500,955
2023-01-30	2023-01-27	4	Koenig Scott	GLYC	Common Stock	M - Exercise	D		2.5500	10,500	27		15,750
2023-01-27	2023-01-26	4	SANDELL SCOTT D See Note 3	GLYC	Common Stock	S - Sale	I		3.1188	-1,351,092	-4,214		2,237,196
2023-01-27	2023-01-26	4	SANDELL SCOTT D See Note 2	GLYC	Common Stock	S - Sale	I		3.1188	-1,648,908	-5,143		2,730,334
2023-01-27	2023-01-25	4	SANDELL SCOTT D See Note 3	GLYC	Common Stock	S - Sale	I		3.2639	-293,645	-958		3,588,288
2023-01-27	2023-01-25	4	SANDELL SCOTT D See Note 2	GLYC	Common Stock	S - Sale	I		3.2639	-358,371	-1,170		4,379,242
2023-01-06	2023-01-05	4	SANDELL SCOTT D See Note 3	GLYC	Common Stock	S - Sale	I		2.7586	-32,139	-89		3,881,933
2023-01-06	2023-01-05	4	SANDELL SCOTT D See Note 2	GLYC	Common Stock	S - Sale	I		2.7586	-39,223	-108		4,737,613
2023-01-04	2023-01-04	4	SANDELL SCOTT D See Note 3	GLYC	Common Stock	S - Sale	I		2.9097	-45,930	-134		3,914,072
2023-01-04	2023-01-04	4	SANDELL SCOTT D See Note 2	GLYC	Common Stock	S - Sale	I		2.9097	-56,054	-163		4,776,836
2023-01-04	2023-01-03	4	SANDELL SCOTT D See Note 3	GLYC	Common Stock	S - Sale	I		2.9901	-78,730	-235		3,960,002
2023-01-04	2023-01-03	4	SANDELL SCOTT D See Note 2	GLYC	Common Stock	S - Sale	I		2.9901	-96,084	-287		4,832,890
2023-01-04	2022-12-30	4	SANDELL SCOTT D See Note 3	GLYC	Common Stock	S - Sale	I		3.0200	-54,645	-165		4,038,732
2023-01-04	2022-12-30	4	SANDELL SCOTT D See Note 2	GLYC	Common Stock	S - Sale	I		3.0200	-66,690	-201		4,928,974
2022-12-27	2022-12-22	4	Rock Edwin	GLYC	Common Stock	P - Purchase	D		2.2500	110,000	248		310,000
2022-11-18	2022-11-17	4	JUNIUS DANIEL M	GLYC	Common Stock	P - Purchase	D		1.8700	20,000	37		63,250
2022-11-16	2022-11-15	4	Rock Edwin	GLYC	Common Stock	P - Purchase	D		1.6600	100,000	166		200,000
2022-11-16	2022-11-14	4	Rock Edwin	GLYC	Common Stock	P - Purchase	D		1.4300	100,000	143		100,000
2022-11-14	2022-11-11	4	Magnani John L.	GLYC	Common Stock	P - Purchase	D		1.1700	45,045	53		366,078
2022-11-14	2022-11-11	4	PEARSON TIMOTHY R	GLYC	Common Stock	P - Purchase	D		1.2900	19,400	25		24,650
2022-11-14	2022-11-11	4	Hahn Brian M.	GLYC	Common Stock	P - Purchase	D		1.0600	20,000	21		56,843
2022-11-14	2022-11-11	4	Semerjian Harout	GLYC	Common Stock	P - Purchase	D		1.2900	25,000	32		25,000
2022-11-14	2022-11-11	4	Girard Armand	GLYC	Common Stock	P - Purchase	D		1.0500	6,500	7		29,161
2022-09-07		3	Rock Edwin	GLYC	No securities beneficially owned		D						0
2022-05-20	2022-05-18	4	PEARSON TIMOTHY R	GLYC	Stock Option (right to buy)	A - Award	D	0.60		21,000		21,000
2022-05-20	2022-05-18	4	Koenig Scott	GLYC	Stock Option (right to buy)	A - Award	D	0.60		21,000		21,000
2022-05-20	2022-05-18	4	King Rachel K.	GLYC	Stock Option (right to buy)	A - Award	D	0.60		21,000		21,000
2022-05-20	2022-05-18	4	JUNIUS DANIEL M	GLYC	Stock Option (right to buy)	A - Award	D	0.60		21,000		21,000
2022-05-20	2022-05-18	4	Jackson Scott Thomas	GLYC	Stock Option (right to buy)	A - Award	D	0.60		21,000		21,000
2022-05-20	2022-05-18	4	Goldberg Mark Alan	GLYC	Stock Option (right to buy)	A - Award	D	0.60		21,000		21,000
2022-05-20	2022-05-18	4	Andrews Patricia S	GLYC	Stock Option (right to buy)	A - Award	D	0.60		21,000		21,000
2022-03-10	2022-03-09	4	Magnani John L.	GLYC	Common Stock	S - Sale	D		1.0900	-3,227	-4		321,033
2022-03-10	2022-03-09	4	Girard Armand	GLYC	Common Stock	S - Sale	D		1.0900	-2,339	-3		22,661
2022-03-10	2022-03-09	4	Hahn Brian M.	GLYC	Common Stock	S - Sale	D		1.0900	-2,917	-3		36,843
2022-01-25	2022-01-21	4	Girard Armand	GLYC	Employee Stock Option (right to buy)	A - Award	D	1.11		47,700		47,700
2022-01-25	2022-01-21	4	Girard Armand	GLYC	Employee Stock Option (right to buy)	A - Award	D	1.11		144,700		144,700
2022-01-25	2022-01-21	4	Magnani John L.	GLYC	Employee Stock Option (right to buy)	A - Award	D	1.11		25,000		25,000
2022-01-25	2022-01-21	4	Magnani John L.	GLYC	Employee Stock Option (right to buy)	A - Award	D	1.11		100,000		100,000
2022-01-25	2022-01-21	4	Hahn Brian M.	GLYC	Employee Stock Option (right to buy)	A - Award	D	1.11		47,700		47,700
2022-01-25	2022-01-21	4	Hahn Brian M.	GLYC	Employee Stock Option (right to buy)	A - Award	D	1.11		164,700		164,700
2022-01-25	2022-01-21	4	Semerjian Harout	GLYC	Employee Stock Option (right to buy)	A - Award	D	1.11		423,500		423,500
2021-11-18	2021-11-16	4	Andrews Patricia S	GLYC	Common Stock	P - Purchase	D		2.0500	40,000	82		45,250
2021-08-10		3	Semerjian Harout	GLYC	No securities beneficially owned		D						0
2021-05-27	2021-05-18	4	JUNIUS DANIEL M	GLYC	Stock Option (right to buy)	A - Award	D	2.55		10,500		10,500
2021-05-27	2021-05-18	4	JUNIUS DANIEL M	GLYC	Common Stock	A - Award	D			5,250			43,250
2021-05-27	2021-05-18	4	Jackson Scott Thomas	GLYC	Stock Option (right to buy)	A - Award	D	2.55		10,500		10,500
2021-05-27	2021-05-18	4	Jackson Scott Thomas	GLYC	Common Stock	A - Award	D			5,250			5,250
2021-05-27	2021-05-18	4	Andrews Patricia S	GLYC	Stock Option (right to buy)	A - Award	D	2.55		10,500		10,500
2021-05-27	2021-05-18	4	Andrews Patricia S	GLYC	Common Stock	A - Award	D			5,250			5,250
2021-05-27	2021-05-18	4	Goldberg Mark Alan	GLYC	Stock Option (right to buy)	A - Award	D	2.55		10,500		10,500
2021-05-27	2021-05-18	4	Goldberg Mark Alan	GLYC	Common Stock	A - Award	D			5,250			5,250
2021-05-27	2021-05-18	4	Koenig Scott	GLYC	Stock Option (right to buy)	A - Award	D	2.55		10,500		10,500
2021-05-27	2021-05-18	4	Koenig Scott	GLYC	Common Stock	A - Award	D			5,250			5,250
2021-05-27	2021-05-18	4	PEARSON TIMOTHY R	GLYC	Stock Option (right to buy)	A - Award	D	2.55		10,500		10,500
2021-05-27	2021-05-18	4	PEARSON TIMOTHY R	GLYC	Common Stock	A - Award	D			5,250			5,250
2021-03-08		3	Feldman Eric Jay	GLYC	Common Stock		D						50,498
2021-01-22	2021-01-20	4	Girard Armand	GLYC	Employee Stock Option (right to buy)	A - Award	D	3.81		50,000		50,000
2021-01-22	2021-01-20	4	Girard Armand	GLYC	Common Stock	A - Award	D			25,000			25,000
2021-01-22	2021-01-20	4	Hahn Brian M.	GLYC	Employee Stock Option (right to buy)	A - Award	D	3.81		69,000		69,000
2021-01-22	2021-01-20	4	Hahn Brian M.	GLYC	Common Stock	A - Award	D			34,500			39,760
2021-01-22	2021-01-20	4	Thackray Helen M.	GLYC	Employee Stock Option (right to buy)	A - Award	D	3.81		69,000		69,000
2021-01-22	2021-01-20	4	Thackray Helen M.	GLYC	Common Stock	A - Award	D			34,500			183,115
2021-01-22	2021-01-20	4	Magnani John L.	GLYC	Employee Stock Option (right to buy)	A - Award	D	3.81		69,000		69,000
2021-01-22	2021-01-20	4	Magnani John L.	GLYC	Common Stock	A - Award	D			34,500			324,260
2021-01-22	2021-01-20	4	King Rachel K.	GLYC	Employee Stock Option (right to buy)	A - Award	D	3.81		192,500		192,500
2021-01-22	2021-01-20	4	King Rachel K.	GLYC	Common Stock	A - Award	D			96,250			452,314
2020-12-30	2020-12-28	4	King Rachel K.	GLYC	Employee Stock Option (right to buy)	M - Exercise	D	1.12		-130,821		0
2020-12-30	2020-12-28	4	King Rachel K.	GLYC	Common Stock	S - Sale	D		3.9100	-84,176	-329		356,064
2020-12-30	2020-12-28	4	King Rachel K.	GLYC	Common Stock	M - Exercise	D		1.1200	130,821	147		440,240
2020-12-17	2020-12-16	4	Hahn Brian M.	GLYC	Employee Stock Option (right to buy)	M - Exercise	D	1.12		-5,260		0
2020-12-17	2020-12-16	4	Hahn Brian M.	GLYC	Common Stock	M - Exercise	D		1.1200	5,260	6		5,260
2020-11-06	2020-11-04	4	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value	P - Purchase	D		2.6000	86,090	224		630,453
2020-11-06	2020-11-04	4	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value	P - Purchase	D		2.6000	506,155	1,316		3,712,350
2020-11-06	2020-11-04	4	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value	P - Purchase	D		2.6000	674,492	1,754		4,980,812
2020-11-03	2020-10-30	4	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value	P - Purchase	D		2.7500	15,472	43		544,363
2020-11-03	2020-10-30	4	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value	P - Purchase	D		2.7500	250,755	690		3,206,195
2020-11-03	2020-10-30	4	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value	P - Purchase	D		2.7500	666,385	1,833		4,306,320
2020-05-27	2020-05-22	4	Andrews Patricia S	GLYC	Stock Option (right to buy)	A - Award	D	3.00		21,000		21,000
2020-05-27	2020-05-22	4	Goldberg Mark Alan	GLYC	Stock Option (right to buy)	A - Award	D	3.00		21,000		21,000
2020-05-27	2020-05-22	4	Jackson Scott Thomas	GLYC	Stock Option (right to buy)	A - Award	D	3.00		21,000		21,000
2020-05-27	2020-05-22	4	Koenig Scott	GLYC	Stock Option (right to buy)	A - Award	D	3.00		21,000		21,000
2020-05-27	2020-05-22	4	PEARSON TIMOTHY R	GLYC	Stock Option (right to buy)	A - Award	D	3.00		21,000		21,000
2020-05-27	2020-05-22	4	JUNIUS DANIEL M	GLYC	Stock Option (right to buy)	A - Award	D	3.00		21,000		21,000
2020-03-10	2020-03-09	4	JUNIUS DANIEL M	GLYC	Common Stock	P - Purchase	D		3.4000	20,000	68		38,000
2020-01-24	2020-01-22	4	King Rachel K.	GLYC	Employee Stock Option (right to buy)	A - Award	D	4.72		349,000		349,000
2020-01-24	2020-01-22	4	Thackray Helen M.	GLYC	Employee Stock Option (right to buy)	A - Award	D	4.72		120,000		120,000
2020-01-24	2020-01-22	4	Hahn Brian M.	GLYC	Employee Stock Option (right to buy)	A - Award	D	4.72		120,000		120,000
2020-01-24	2020-01-22	4	Magnani John L.	GLYC	Employee Stock Option (right to buy)	A - Award	D	4.72		120,000		120,000
2020-01-24	2020-01-22	4	Girard Armand	GLYC	Employee Stock Option (right to buy)	A - Award	D	4.72		100,000		100,000
2020-01-06	2020-01-06	4	Magnani John L.	GLYC	Employee Stock Option (right to buy)	M - Exercise	D	1.12		-106,983		0
2020-01-06	2020-01-06	4	Magnani John L.	GLYC	Common Stock	M - Exercise	D		1.1200	106,983	120		289,760
2019-12-23	2019-12-20	4	Magnani John L.	GLYC	Employee Stock Option (right to buy)	M - Exercise	D	1.12		-106,984		106,983
2019-12-23	2019-12-20	4	Magnani John L.	GLYC	Common Stock	M - Exercise	D		1.1200	106,984	120		182,777
2019-09-09	2019-09-05	4	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value	P - Purchase	D		3.1820	124,956	398		528,891
2019-09-09	2019-09-05	4	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value	P - Purchase	D		3.1820	689,834	2,195		2,955,440
2019-09-09	2019-09-05	4	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value	P - Purchase	D		3.1820	853,956	2,717		3,639,935
2019-08-26		3	LAMPERT MARK N	GLYC	Common Stock, $0.001 par value		D						5,859,455
2019-08-26		3	LAMPERT MARK N	GLYC	Common Stock, $0.001 par value		D						7,721,126
2019-08-26		3	LAMPERT MARK N	GLYC	Common Stock, $0.001 par value		D						5,859,455
2019-08-26		3	LAMPERT MARK N	GLYC	Common Stock, $0.001 par value		D						8,241,499
2019-08-26		3	LAMPERT MARK N	GLYC	Common Stock, $0.001 par value		D						7,721,126
2019-08-26		3	LAMPERT MARK N	GLYC	Common Stock, $0.001 par value		D						5,859,455
2019-08-26		3	LAMPERT MARK N	GLYC	Common Stock, $0.001 par value		D						8,241,499
2019-08-26		3	LAMPERT MARK N	GLYC	Common Stock, $0.001 par value		D						7,721,126
2019-08-26		3	LAMPERT MARK N	GLYC	Common Stock, $0.001 par value		D						5,859,455
2019-08-26		3	LAMPERT MARK N	GLYC	Common Stock, $0.001 par value		D						8,241,499
2019-08-26		3	LAMPERT MARK N	GLYC	Common Stock, $0.001 par value		D						7,721,126
2019-08-26		3	LAMPERT MARK N	GLYC	Common Stock, $0.001 par value		D						5,859,455
2019-08-26		3	LAMPERT MARK N	GLYC	Common Stock, $0.001 par value		D						8,241,499
2019-08-26		3	LAMPERT MARK N	GLYC	Common Stock, $0.001 par value		D						7,721,126
2019-08-26		3	LAMPERT MARK N	GLYC	Common Stock, $0.001 par value		D						5,859,455
2019-08-26		3	LAMPERT MARK N	GLYC	Common Stock, $0.001 par value		D						8,241,499
2019-08-26		3	LAMPERT MARK N	GLYC	Common Stock, $0.001 par value		D						7,721,126
2019-08-26		3	LAMPERT MARK N	GLYC	Common Stock, $0.001 par value		D						5,859,455
2019-08-26		3	LAMPERT MARK N	GLYC	Common Stock, $0.001 par value		D						8,241,499
2019-08-26		3	LAMPERT MARK N	GLYC	Common Stock, $0.001 par value		D						7,721,126
2019-08-26		3	LAMPERT MARK N	GLYC	Common Stock, $0.001 par value		D						7,721,126
2019-08-26		3	LAMPERT MARK N	GLYC	Common Stock, $0.001 par value		D						5,859,455
2019-08-26		3	LAMPERT MARK N	GLYC	Common Stock, $0.001 par value		D						8,241,499
2019-08-26		3	LAMPERT MARK N	GLYC	Common Stock, $0.001 par value		D						8,241,499
2019-08-26		3	LAMPERT MARK N	GLYC	Common Stock, $0.001 par value		D						7,721,126
2019-08-26		3	LAMPERT MARK N	GLYC	Common Stock, $0.001 par value		D						5,859,455
2019-08-26		3	LAMPERT MARK N	GLYC	Common Stock, $0.001 par value		D						8,241,499
2019-08-15	2019-08-13	4	JUNIUS DANIEL M	GLYC	Common Stock	P - Purchase	D		3.1800	10,000	32		18,000
2019-08-07	2019-08-06	4	King Rachel K.	GLYC	Employee Stock Option (right to buy)	M - Exercise	D	1.12		-166,759		130,821
2019-08-07	2019-08-06	4	King Rachel K.	GLYC	Common Stock	M - Exercise	D		1.1200	166,759	187		307,144
2019-05-21	2019-05-17	4	Koenig Scott	GLYC	Stock Option (right to buy)	A - Award	D	12.39		21,000		21,000
2019-05-21	2019-05-17	4	JUNIUS DANIEL M	GLYC	Stock Option (right to buy)	A - Award	D	12.39		21,000		21,000
2019-05-21	2019-05-17	4	Andrews Patricia S	GLYC	Stock Option (right to buy)	A - Award	D	12.39		21,000		21,000
2019-05-21	2019-05-17	4	Jackson Scott Thomas	GLYC	Stock Option (right to buy)	A - Award	D	12.39		21,000		21,000
2019-05-21	2019-05-17	4	Goldberg Mark Alan	GLYC	Stock Option (right to buy)	A - Award	D	12.39		21,000		21,000
2019-05-21	2019-05-17	4	PEARSON TIMOTHY R	GLYC	Common Stock	A - Award	D	12.39		21,000		21,000
2019-01-22	2019-01-17	4	Hahn Brian M.	GLYC	Employee Stock Option (right to buy)	A - Award	D	10.59		90,000		90,000
2019-01-22	2019-01-17	4	Thackray Helen M.	GLYC	Employee Stock Option (right to buy)	A - Award	D	10.59		100,000		100,000
2019-01-22	2019-01-17	4	Magnani John L.	GLYC	Employee Stock Option (right to buy)	A - Award	D	10.59		100,000		100,000
2019-01-22	2019-01-17	4	King Rachel K.	GLYC	Employee Stock Option (right to buy)	A - Award	D	10.59		265,000		265,000
2018-11-28		3	Jackson Scott Thomas	GLYC	No securities beneficially owned		D						0
2018-11-28	2018-11-27	4	Jackson Scott Thomas	GLYC	Stock Option (right to buy)	A - Award	D	11.52		22,000		22,000
2018-10-18	2018-10-18	4	Magnani John L.	GLYC	Common Stock	S - Sale	D		14.0200	-3,527	-49		75,793
2018-10-18	2018-10-17	4	Magnani John L.	GLYC	Common Stock	S - Sale	D		14.0000	-7,273	-102		79,320
2018-10-18	2018-10-16	4	Magnani John L.	GLYC	Common Stock	S - Sale	D		14.0100	-14,200	-199		86,593
2018-06-12	2018-06-11	4	Hahn Brian M.	GLYC	Employee Stock Option (right to buy)	M - Exercise	D	1.12		-5,260		5,260
2018-06-12	2018-06-11	4	Hahn Brian M.	GLYC	Common Stock	S - Sale	D		18.0400	-19,345	-349		0
2018-06-12	2018-06-11	4	Hahn Brian M.	GLYC	Common Stock	M - Exercise	D		1.1200	5,260	6		19,345
2018-05-24	2018-05-23	4	Magnani John L.	GLYC	Warrant to Purchase Common Stock (right to buy)	M - Exercise	D	0.33		-596		0
2018-05-24	2018-05-23	4	Magnani John L.	GLYC	Warrant to Purchase Common Stock (right to buy)	M - Exercise	D	0.33		-895		0
2018-05-24	2018-05-23	4	Magnani John L.	GLYC	Common Stock	M - Exercise	D		0.3300	1,491	0		100,793
2018-05-21	2018-05-18	4	BARRETT M JAMES	GLYC	Stock Option (right to buy)	A - Award	D	18.41		11,000		11,000
2018-05-21	2018-05-18	4	Andrews Patricia S	GLYC	Stock Option (right to buy)	A - Award	D	18.41		11,000		11,000
2018-05-21	2018-05-18	4	PEARSON TIMOTHY R	GLYC	Stock Option (right to buy)	A - Award	D	18.41		11,000		11,000
2018-05-21	2018-05-18	4	Koenig Scott	GLYC	Stock Option (right to buy)	A - Award	D	18.41		11,000		11,000
2018-05-21	2018-05-18	4	JUNIUS DANIEL M	GLYC	Stock Option (right to buy)	A - Award	D	18.41		11,000		11,000
2018-05-21	2018-05-18	4	Goldberg Mark Alan	GLYC	Stock Option (right to buy)	A - Award	D	18.41		11,000		11,000
2018-05-11	2018-05-10	4	NEW ENTERPRISE ASSOCIATES 10 L P	GLYC	Warrant to Purchase Common Stock (right to buy)	X - Other	D	0.33		-298,406		0
2018-05-11	2018-05-10	4	NEW ENTERPRISE ASSOCIATES 10 L P	GLYC	Warrant to Purchase Common Stock (right to buy)	X - Other	D	0.33		-216,046		0
2018-05-11	2018-05-10	4	NEW ENTERPRISE ASSOCIATES 10 L P	GLYC	Common Stock	S - Sale	D		17.8100	-5,533	-99		4,995,664
2018-05-11	2018-05-10	4	NEW ENTERPRISE ASSOCIATES 10 L P	GLYC	Common Stock	X - Other	D		0.3300	298,406	98		5,001,197
2018-05-11	2018-05-10	4	NEW ENTERPRISE ASSOCIATES 10 L P	GLYC	Common Stock	S - Sale	D		17.8100	-4,006	-71		4,702,791
2018-05-11	2018-05-10	4	NEW ENTERPRISE ASSOCIATES 10 L P	GLYC	Common Stock	X - Other	D		0.3300	216,046	71		4,706,797
2018-05-11	2018-05-10	4	BARRETT M JAMES See Note 1	GLYC	Warrant to Purchase Common Stock (right to buy)	X - Other	I	0.33		-298,406		0
2018-05-11	2018-05-10	4	BARRETT M JAMES See Note 1	GLYC	Warrant to Purchase Common Stock (right to buy)	X - Other	I	0.33		-216,046		0
2018-05-11	2018-05-10	4	BARRETT M JAMES See Note 1	GLYC	Common Stock	S - Sale	I		17.8100	-5,533	-99		4,995,664
2018-05-11	2018-05-10	4	BARRETT M JAMES See Note 1	GLYC	Common Stock	X - Other	I		0.3300	298,406	98		5,001,197
2018-05-11	2018-05-10	4	BARRETT M JAMES See Note 1	GLYC	Common Stock	S - Sale	I		17.8100	-4,006	-71		4,702,791
2018-05-11	2018-05-10	4	BARRETT M JAMES See Note 1	GLYC	Common Stock	X - Other	I		0.3300	216,046	71		4,706,797
2018-05-11	2018-05-10	4	BARRIS PETER J See Note 1	GLYC	Warrant to Purchase Common Stock (right to buy)	X - Other	I	0.33		-298,406		0
2018-05-11	2018-05-10	4	BARRIS PETER J See Note 1	GLYC	Warrant to Purchase Common Stock (right to buy)	X - Other	I	0.33		-216,046		0
2018-05-11	2018-05-10	4	BARRIS PETER J See Note 1	GLYC	Common Stock	S - Sale	I		17.8100	-5,533	-99		4,995,664
2018-05-11	2018-05-10	4	BARRIS PETER J See Note 1	GLYC	Common Stock	X - Other	I		0.3300	298,406	98		5,001,197
2018-05-11	2018-05-10	4	BARRIS PETER J See Note 1	GLYC	Common Stock	S - Sale	I		17.8100	-4,006	-71		4,702,791
2018-05-11	2018-05-10	4	BARRIS PETER J See Note 1	GLYC	Common Stock	X - Other	I		0.3300	216,046	71		4,706,797
2018-05-11	2018-05-10	4	SANDELL SCOTT D See Note 1	GLYC	Warrant to Purchase Common Stock (right to buy)	X - Other	I	0.33		-298,406		0
2018-05-11	2018-05-10	4	SANDELL SCOTT D See Note 1	GLYC	Warrant to Purchase Common Stock (right to buy)	X - Other	I	0.33		-216,046		0
2018-05-11	2018-05-10	4	SANDELL SCOTT D See Note 1	GLYC	Common Stock	S - Sale	I		17.8100	-5,533	-99		4,995,664
2018-05-11	2018-05-10	4	SANDELL SCOTT D See Note 1	GLYC	Common Stock	X - Other	I		0.3300	298,406	98		5,001,197
2018-05-11	2018-05-10	4	SANDELL SCOTT D See Note 1	GLYC	Common Stock	S - Sale	I		17.8100	-4,006	-71		4,702,791
2018-05-11	2018-05-10	4	SANDELL SCOTT D See Note 1	GLYC	Common Stock	X - Other	I		0.3300	216,046	71		4,706,797
2018-02-14	2017-09-08	5	King Rachel K. By The Rachel K. King 2013 GRAT	GLYC	Common Stock	G - Gift	I			-46,602			0
2018-02-14	2017-09-08	5	King Rachel K. By Langley King 2013 GRAT	GLYC	Common Stock	G - Gift	I			23,301			23,301
2018-02-14	2017-09-08	5	King Rachel K. By Connor King 2013 GRAT	GLYC	Common Stock	G - Gift	I			23,301			23,301
2018-01-12	2018-01-10	4	Hahn Brian M.	GLYC	Employee Stock Option (right to buy)	A - Award	D	20.03		65,000		65,000
2018-01-12	2018-01-10	4	Magnani John L.	GLYC	Employee Stock Option (right to buy)	A - Award	D	20.03		75,000		75,000
2018-01-12	2018-01-10	4	Thackray Helen M.	GLYC	Employee Stock Option (right to buy)	A - Award	D	20.03		75,000		75,000
2018-01-12	2018-01-10	4	King Rachel K.	GLYC	Employee Stock Option (right to buy)	A - Award	D	20.03		175,000		175,000
2017-12-12	2017-12-08	4	Thackray Helen M.	GLYC	Common Stock	S - Sale	D		15.0100	-2,000	-30		148,615
2017-09-18	2017-09-18	4	Thackray Helen M.	GLYC	Common Stock	S - Sale	D		13.0000	-2,000	-26		150,615
2017-06-16	2017-06-15	4	JUNIUS DANIEL M	GLYC	Common Stock	A - Award	D		11.2700	3,000	34		8,000
2017-06-12		3	Andrews Patricia S	GLYC	No securities beneficially owned		D						0
2017-06-12	2017-06-09	4	Andrews Patricia S	GLYC	Stock Option (right to buy)	A - Award	D	11.63		22,000		22,000
2017-05-30	2017-05-25	4	BARRETT M JAMES	GLYC	Stock Option (right to buy)	A - Award	D	13.89		11,000		11,000
2017-05-30	2017-05-25	4	Thackray Helen M.	GLYC	Common Stock	S - Sale	D		15.5700	-2,000	-31		152,615
2017-05-30	2017-05-25	4	Goldberg Mark Alan	GLYC	Stock Option (right to buy)	A - Award	D	13.89		11,000		11,000
2017-05-30	2017-05-25	4	JUNIUS DANIEL M	GLYC	Stock Option (right to buy)	A - Award	D	13.89		11,000		11,000
2017-05-30	2017-05-25	4	Koenig Scott	GLYC	Stock Option (right to buy)	A - Award	D	13.89		11,000		11,000
2017-05-30	2017-05-25	4	PEARSON TIMOTHY R	GLYC	Stock Option (right to buy)	A - Award	D	13.89		11,000		11,000
2017-05-22	2017-05-19	4	Thackray Helen M.	GLYC	Common Stock	S - Sale	D		12.1400	-2,000	-24		154,615
2017-05-11		3	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value per share		D						3,319,001
2017-05-11		3	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value per share		D						4,665,288
2017-05-11		3	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value per share		D						4,098,367
2017-05-11		3	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value per share		D						3,319,001
2017-05-11		3	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value per share		D						4,665,288
2017-05-11		3	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value per share		D						4,098,367
2017-05-11		3	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value per share		D						3,319,001
2017-05-11		3	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value per share		D						4,665,288
2017-05-11		3	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value per share		D						4,098,367
2017-05-11		3	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value per share		D						3,319,001
2017-05-11		3	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value per share		D						4,665,288
2017-05-11		3	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value per share		D						4,098,367
2017-05-11		3	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value per share		D						3,319,001
2017-05-11		3	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value per share		D						4,665,288
2017-05-11		3	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value per share		D						4,098,367
2017-05-11		3	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value per share		D						4,665,288
2017-05-11		3	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value per share		D						4,098,367
2017-05-11		3	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value per share		D						3,319,001
2017-05-11		3	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value per share		D						4,665,288
2017-05-11		3	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value per share		D						4,098,367
2017-05-11		3	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value per share		D						3,319,001
2017-05-11		3	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value per share		D						4,665,288
2017-05-11		3	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value per share		D						4,098,367
2017-05-11		3	BVF PARTNERS L P/IL	GLYC	Common Stock, $0.001 par value per share		D						3,319,001
2017-05-11	2017-05-10	4	Magnani John L.	GLYC	Employee Stock Option (right to buy)	M - Exercise	D	1.12		-8,928		213,967
2017-05-11	2017-05-10	4	Magnani John L.	GLYC	Common Stock	M - Exercise	D		1.1200	8,928	10		99,302
2017-03-13		3	Koenig Scott	GLYC	No securities beneficially owned		D						0
2017-03-13	2017-03-09	4	Koenig Scott	GLYC	Stock Option (right to buy)	A - Award	D	6.59		22,000		22,000
2017-01-05	2017-01-04	4	Hahn Brian M.	GLYC	Employee Stock Option (right to buy)	A - Award	D	6.33		65,000		65,000
2017-01-05	2017-01-04	4	King Rachel K.	GLYC	Employee Stock Option (right to buy)	A - Award	D	6.33		175,000		175,000
2017-01-05	2017-01-04	4	Magnani John L.	GLYC	Employee Stock Option (right to buy)	A - Award	D	6.33		75,000		75,000
2017-01-05	2017-01-04	4	Thackray Helen M.	GLYC	Employee Stock Option (right to buy)	A - Award	D	6.33		75,000		75,000
2016-12-21	2016-12-20	4	JUNIUS DANIEL M	GLYC	Common Stock	P - Purchase	D		6.0100	5,000	30		5,000
2016-10-04	2016-10-03	4	Thackray Helen M.	GLYC	Common Stock	S - Sale	D		7.0100	-100	-1		156,615
2016-10-04	2016-10-03	4	Thackray Helen M.	GLYC	Common Stock	S - Sale	D		7.0000	-3,900	-27		156,715
2016-07-21	2016-07-20	4	Thackray Helen M.	GLYC	Common Stock	S - Sale	D		8.0000	-2,000	-16		160,615
2016-07-06	2016-07-06	4	Thackray Helen M.	GLYC	Common Stock	S - Sale	D		6.6800	-6,796	-45		162,615
2016-07-06	2016-07-05	4	Thackray Helen M.	GLYC	Common Stock	S - Sale	D		7.0100	-10,136	-71		169,411
2016-07-06	2016-07-01	4	Thackray Helen M.	GLYC	Common Stock	S - Sale	D		7.4000	-5,068	-38		179,547
2016-07-01	2016-06-29	4	Baldwin John J.	GLYC	Stock Option (right to buy)	M - Exercise	D	1.12		-605		0
2016-07-01	2016-06-29	4	Baldwin John J.	GLYC	Common Stock	M - Exercise	D		1.1200	605	1		1,210
2016-05-19	2016-05-17	4/A	PEARSON TIMOTHY R	GLYC	Stock Option (right to buy)	A - Award	D	6.35		11,000		11,000
2016-05-19	2016-05-17	4	TOP FRANKLIN H JR	GLYC	Stock Option (right to buy)	A - Award	D	6.35		11,000		11,000
2016-05-19	2016-05-17	4	JUNIUS DANIEL M	GLYC	Stock Option (right to buy)	A - Award	D	6.35		11,000		11,000
2016-05-19	2016-05-17	4	BARRETT M JAMES	GLYC	Stock Option (right to buy)	A - Award	D	6.35		11,000		11,000
2016-05-19	2016-05-17	4	PEARSON TIMOTHY R	GLYC	Stock Option (right to buy)	A - Award	D	6.35		11,000		11,000
2016-05-19	2016-05-17	4	Goldberg Mark Alan	GLYC	Stock Option (right to buy)	A - Award	D	6.35		11,000		11,000
2016-05-19	2016-05-17	4	Baldwin John J.	GLYC	Stock Option (right to buy)	A - Award	D	6.35		11,000		11,000
2016-03-21		3	JUNIUS DANIEL M	GLYC	No securities beneficially owned		D						0
2016-03-21	2016-03-17	4	JUNIUS DANIEL M	GLYC	Stock Option (right to buy)	A - Award	D	5.99		22,000		22,000
2016-03-07	2016-03-04	4	Goldberg Mark Alan	GLYC	Common Stock	P - Purchase	D		4.7735	10,397	50		11,497
2016-02-12	2016-02-05	4	TOP FRANKLIN H JR	GLYC	Stock Option (right to buy)	M - Exercise	D	1.12	1.1200	-11,084	-12	0
2016-02-12	2016-02-05	4	TOP FRANKLIN H JR	GLYC	Stock Option (right to buy)	M - Exercise	D	1.12	1.1200	-605	-1	0
2016-02-12	2016-02-05	4	TOP FRANKLIN H JR	GLYC	Common Stock	M - Exercise	D		1.1200	11,689	13		12,294
2016-01-11	2016-01-07	4	Hahn Brian M.	GLYC	Employee Stock Option (right to buy)	A - Award	D	5.22		65,000		65,000
2016-01-11	2016-01-07	4	King Rachel K.	GLYC	Employee Stock Option (right to buy)	A - Award	D	5.22		141,000		141,000
2016-01-11	2016-01-07	4	Magnani John L.	GLYC	Employee Stock Option (right to buy)	A - Award	D	5.22		71,000		71,000
2016-01-11	2016-01-07	4	Thackray Helen M.	GLYC	Employee Stock Option (right to buy)	A - Award	D	5.22		71,000		71,000
2015-11-18	2015-11-16	4	SANDELL SCOTT D See Note 1	GLYC	Warrant to Purchase Common Stock (right to buy)	X - Other	I	0.33	0.3300	-9,445	-3	0
2015-11-18	2015-11-16	4	SANDELL SCOTT D See Note 1	GLYC	Common Stock	S - Sale	I		6.9100	-452	-3		4,490,751
2015-11-18	2015-11-16	4	SANDELL SCOTT D See Note 1	GLYC	Common Stock	X - Other	I		0.3300	9,445	3		4,491,203
2015-11-18	2015-11-16	4	BARRETT M JAMES See Note 1	GLYC	Warrant to Purchase Common Stock (right to buy)	X - Other	I	0.33	0.3300	-9,445	-3	0
2015-11-18	2015-11-16	4	BARRETT M JAMES See Note 1	GLYC	Common Stock	S - Sale	I		6.9100	-452	-3		4,490,751
2015-11-18	2015-11-16	4	BARRETT M JAMES See Note 1	GLYC	Common Stock	X - Other	I		0.3300	9,445	3		4,491,203
2015-11-18	2015-11-16	4	NEW ENTERPRISE ASSOCIATES 10 L P	GLYC	Warrant to Purchase Common Stock (right to buy)	X - Other	D	0.33	0.3300	-9,445	-3	0
2015-11-18	2015-11-16	4	NEW ENTERPRISE ASSOCIATES 10 L P	GLYC	Common Stock	S - Sale	D		6.9100	-452	-3		4,490,751
2015-11-18	2015-11-16	4	NEW ENTERPRISE ASSOCIATES 10 L P	GLYC	Common Stock	X - Other	D		0.3300	9,445	3		4,491,203
2015-11-18	2015-11-16	4	BARRIS PETER J See Note 1	GLYC	Warrant to Purchase Common Stock (right to buy)	X - Other	I	0.33	0.3300	-9,445	-3	0
2015-11-18	2015-11-16	4	BARRIS PETER J See Note 1	GLYC	Common Stock	S - Sale	I		6.9100	-452	-3		4,490,751
2015-11-18	2015-11-16	4	BARRIS PETER J See Note 1	GLYC	Common Stock	X - Other	I		0.3300	9,445	3		4,491,203
2015-08-11	2015-07-15	4	PEARSON TIMOTHY R	GLYC	Stock Option (right to buy)	A - Award	D	7.50		11,000		11,000
2015-08-11	2015-07-15	4	Baldwin John J.	GLYC	Stock Option (right to buy)	A - Award	D	7.50		11,000		11,000
2015-08-11	2015-07-15	4	Goldberg Mark Alan	GLYC	Stock Option (right to buy)	A - Award	D	7.50		11,000		11,000
2015-08-11	2015-07-15	4	HENOS MICHAEL A	GLYC	Stock Option (right to buy)	A - Award	D	7.50		11,000		11,000
2015-08-11	2015-07-15	4	TOP FRANKLIN H JR	GLYC	Stock Option (right to buy)	A - Award	D	7.50		11,000		11,000
2015-08-11	2015-07-15	4	BARRETT M JAMES	GLYC	Stock Option (right to buy)	A - Award	D	7.50		11,000		11,000
2015-03-03	2015-02-27	4	Hahn Brian M.	GLYC	Employee Stock Option (right to buy)	M - Exercise	D	1.12		-5,000		10,520
2015-03-03	2015-02-27	4	Hahn Brian M.	GLYC	Common Stock	M - Exercise	D		1.1200	5,000	6		14,085
2015-02-26	2015-02-24	4	King Rachel K.	GLYC	Employee Stock Option (right to buy)	M - Exercise	D	1.12		-50,000		297,580
2015-02-26	2015-02-24	4	King Rachel K.	GLYC	Common Stock	M - Exercise	D		1.1200	50,000	56		167,206
2015-01-12	2015-01-08	4	Thackray Helen M.	GLYC	Employee Stock Option (right to buy)	A - Award	D	7.15		71,000		71,000
2015-01-12	2015-01-08	4	Hahn Brian M.	GLYC	Employee Stock Option (right to buy)	A - Award	D	7.15		61,000		61,000
2015-01-12	2015-01-08	4	Magnani John L.	GLYC	Employee Stock Option (right to buy)	A - Award	D	7.15		71,000		71,000
2015-01-12	2015-01-08	4	King Rachel K.	GLYC	Employee Stock Option (right to buy)	A - Award	D	7.15		141,000		141,000
2014-12-23	2014-12-22	4	HENOS MICHAEL A By fund	GLYC	Common Stock	S - Sale	I		8.4354	-10,659	-90		469,454
2014-12-23	2014-12-19	4	HENOS MICHAEL A By fund	GLYC	Common Stock	S - Sale	I		8.6127	-10,598	-91		480,113
2014-12-17	2014-12-17	4	HENOS MICHAEL A By funds	GLYC	Common Stock	S - Sale	I		8.9700	-5,121	-46		490,711
2014-12-17	2014-12-15	4	HENOS MICHAEL A By funds	GLYC	Warrant to Purchase Common Stock (right to buy)	X - Other	I	0.33		-38,493		0
2014-12-17	2014-12-15	4	HENOS MICHAEL A By funds	GLYC	Warrant to Purchase Common Stock (right to buy)	X - Other	I	0.33		-5,133		0
2014-12-17	2014-12-15	4	HENOS MICHAEL A By funds	GLYC	Common Stock	S - Sale	I		8.9800	-1,604	-14		495,832
2014-12-17	2014-12-15	4	HENOS MICHAEL A By funds	GLYC	Common Stock	X - Other	I		0.3300	43,628	14		497,436
2014-07-10		3	Goldberg Mark Alan	GLYC	Common Stock		D						2,200
2014-07-10		3	Goldberg Mark Alan	GLYC	Common Stock		D						2,200
2014-07-10	2014-07-08	4	Goldberg Mark Alan	GLYC	Stock Option (right to buy)	A - Award	D	8.86		15,401		15,401
2014-06-20	2014-06-18	4	King Rachel K.	GLYC	Employee Stock Option (right to buy)	M - Exercise	D	1.12		-100,000		347,580
2014-06-20	2014-06-18	4	King Rachel K.	GLYC	Common Stock	M - Exercise	D		1.1200	100,000	112		108,706
2014-06-13	2014-06-13	4	HENOS MICHAEL A	GLYC	Common Stock	P - Purchase	D		6.2100	5,000	31		12,562
2014-06-13	2014-06-12	4	HENOS MICHAEL A	GLYC	Common Stock	P - Purchase	D		6.5400	6,000	39		7,562
2014-04-03	2014-04-03	4	HENOS MICHAEL A	GLYC	Stock Option (right to buy)	M - Exercise	D	1.12		-1,562		0
2014-04-03	2014-04-03	4	HENOS MICHAEL A	GLYC	Common Stock	M - Exercise	D		1.1200	1,562	2		1,562
2014-04-01		3	PEARSON TIMOTHY R	GLYC	No securities beneficially owned		D						0
2014-04-01	2014-03-31	4	PEARSON TIMOTHY R	GLYC	Stock Option (right to buy)	A - Award	D	16.33		15,401		15,401
2014-01-15	2014-01-15	4	NEW ENTERPRISE ASSOCIATES 10 L P	GLYC	Series A-1 Preferred Stock	C - Conversion	D			-11,250,850		0
2014-01-15	2014-01-15	4	NEW ENTERPRISE ASSOCIATES 10 L P	GLYC	Common Stock	P - Purchase	D		8.0000	487,500	3,900		4,481,758
2014-01-15	2014-01-15	4	NEW ENTERPRISE ASSOCIATES 10 L P	GLYC	Common Stock	C - Conversion	D			3,407,283			3,994,258
2014-01-15	2014-01-15	4	BARRETT M JAMES See Note 4	GLYC	Series A-1 Preferred Stock	C - Conversion	I			-11,824,058		0
2014-01-15	2014-01-15	4	BARRETT M JAMES See Note 3	GLYC	Series A-1 Preferred Stock	C - Conversion	I			-11,250,850		0
2014-01-15	2014-01-15	4	BARRETT M JAMES See Note 4	GLYC	Common Stock	P - Purchase	I		8.0000	512,500	4,100		4,093,377
2014-01-15	2014-01-15	4	BARRETT M JAMES See Note 4	GLYC	Common Stock	C - Conversion	I			3,580,877			3,580,877
2014-01-15	2014-01-15	4	BARRETT M JAMES See Note 3	GLYC	Common Stock	P - Purchase	I		8.0000	487,500	3,900		4,481,758
2014-01-15	2014-01-15	4	BARRETT M JAMES See Note 3	GLYC	Common Stock	C - Conversion	I			3,407,283			3,994,258
2014-01-15	2014-01-15	4	BARRIS PETER J See Note 4	GLYC	Series A-1 Preferred Stock	C - Conversion	I			-11,824,058		0
2014-01-15	2014-01-15	4	BARRIS PETER J See Note 3	GLYC	Series A-1 Preferred Stock	C - Conversion	I			-11,250,850		0
2014-01-15	2014-01-15	4	BARRIS PETER J See Note 4	GLYC	Common Stock	P - Purchase	I		8.0000	512,500	4,100		4,093,377
2014-01-15	2014-01-15	4	BARRIS PETER J See Note 4	GLYC	Common Stock	C - Conversion	I			3,580,877			3,580,877
2014-01-15	2014-01-15	4	BARRIS PETER J See Note 3	GLYC	Common Stock	P - Purchase	I		8.0000	487,500	3,900		4,481,758
2014-01-15	2014-01-15	4	BARRIS PETER J See Note 3	GLYC	Common Stock	C - Conversion	I			3,407,283			3,994,258
2014-01-15	2014-01-15	4	SANDELL SCOTT D See Note 4	GLYC	Series A-1 Preferred Stock	C - Conversion	I			-11,824,058		0
2014-01-15	2014-01-15	4	SANDELL SCOTT D See Note 3	GLYC	Series A-1 Preferred Stock	C - Conversion	I			-11,250,850		0
2014-01-15	2014-01-15	4	SANDELL SCOTT D See Note 4	GLYC	Common Stock	P - Purchase	I		8.0000	512,500	4,100		4,093,377
2014-01-15	2014-01-15	4	SANDELL SCOTT D See Note 4	GLYC	Common Stock	C - Conversion	I			3,580,877			3,580,877
2014-01-15	2014-01-15	4	SANDELL SCOTT D See Note 3	GLYC	Common Stock	P - Purchase	I		8.0000	487,500	3,900		4,481,758
2014-01-15	2014-01-15	4	SANDELL SCOTT D See Note 3	GLYC	Common Stock	C - Conversion	I			3,407,283			3,994,258
2014-01-15	2014-01-15	4	HENOS MICHAEL A By Funds	GLYC	Series A-1 Preferred Stock	C - Conversion	I			-1,114,690		0
2014-01-15	2014-01-15	4	HENOS MICHAEL A By Spouse	GLYC	Series A-1 Preferred Stock	C - Conversion	I			-39,413		0
2014-01-15	2014-01-15	4	HENOS MICHAEL A By Funds	GLYC	Common Stock	C - Conversion	I			337,579			453,808
2014-01-15	2014-01-15	4	HENOS MICHAEL A By Spouse	GLYC	Common Stock	C - Conversion	I			11,936			22,668
2014-01-15	2014-01-15	4	NEW ENTERPRISE ASSOCIATES 13 LP	GLYC	Series A-1 Preferred Stock	C - Conversion	D			-11,824,058		0
2014-01-15	2014-01-15	4	NEW ENTERPRISE ASSOCIATES 13 LP	GLYC	Common Stock	P - Purchase	D		8.0000	512,500	4,100		4,093,377
2014-01-15	2014-01-15	4	NEW ENTERPRISE ASSOCIATES 13 LP	GLYC	Common Stock	C - Conversion	D			3,580,877			3,580,877
2014-01-15	2014-01-15	4	Magnani John L.	GLYC	Series A-1 Preferred Stock	C - Conversion	D			-32,918		0
2014-01-15	2014-01-15	4	Magnani John L.	GLYC	Common Stock	C - Conversion	D			-9,969			90,374
2014-01-15	2014-01-15	4	Gust William M. By Anthem Capital	GLYC	Series A-1 Preferred Stock	C - Conversion	I			-1,121,646		0
2014-01-15	2014-01-15	4	Gust William M. By Anthem Capital	GLYC	Common Stock	C - Conversion	I			339,686			409,947
2014-01-13	2014-01-09	4	BARRETT M JAMES	GLYC	Stock Option (right to buy)	A - Award	D	8.00		15,401		15,401
2014-01-13	2014-01-09	4	HENOS MICHAEL A	GLYC	Stock Option (right to buy)	A - Award	D	8.00		15,401		15,401
2014-01-13	2014-01-09	4	TOP FRANKLIN H JR	GLYC	Stock Option (right to buy)	A - Award	D	8.00		15,401		15,401
2014-01-13	2014-01-09	4	Hahn Brian M.	GLYC	Stock Option (right to buy)	A - Award	D	8.00		37,564		37,564
2014-01-13	2014-01-09	4	King Rachel K.	GLYC	Stock Option (right to buy)	A - Award	D	8.00		375,639		375,639
2014-01-13	2014-01-09	4	Gust William M.	GLYC	Stock Option (right to buy)	A - Award	D	8.00		15,401		15,401
2014-01-13	2014-01-09	4	Magnani John L.	GLYC	Stock Option (right to buy)	A - Award	D	8.00		169,038		169,038
2014-01-13	2014-01-09	4	Thackray Helen M.	GLYC	Stock Option (right to buy)	A - Award	D	8.00		112,692		112,692
2014-01-13	2014-01-09	4	Baldwin John J.	GLYC	Stock Option (right to buy)	A - Award	D	8.00		15,401		15,401
2014-01-09		3	NEA PARTNERS 10 L P	GLYC	Common Stock		D						586,975
2014-01-09		3	BARRETT M JAMES See Note 1	GLYC	Common Stock		I						586,975
2014-01-09		3	SANDELL SCOTT D See Note 1	GLYC	Common Stock		I						586,975
2014-01-09		3	BARRIS PETER J See Note 1	GLYC	Common Stock		I						586,975
2014-01-09		3	HENOS MICHAEL A By Spouse	GLYC	Common Stock		I						10,732
2014-01-09		3	HENOS MICHAEL A By Funds	GLYC	Common Stock		I						116,229
2014-01-09		3	TOP FRANKLIN H JR	GLYC	Common Stock		D						605
2014-01-09		3	Hahn Brian M.	GLYC	Common Stock		D						9,085
2014-01-09		3	King Rachel K. By Trusts	GLYC	Common Stock		I						157,355
2014-01-09		3	King Rachel K.	GLYC	Common Stock		D						8,706
2014-01-09		3	King Rachel K. By Spouse	GLYC	Common Stock		I						1,741
2014-01-09		3	Magnani John L.	GLYC	Common Stock		D						80,405
2014-01-09		3	Magnani John L. By GlycoTech Corporation	GLYC	Common Stock		I						4,845
2014-01-09		3	Gust William M. By Anthem Capital	GLYC	Common Stock		I						70,261
2014-01-09		3	Thackray Helen M.	GLYC	Common Stock		D						184,615
2014-01-09		3	Baldwin John J.	GLYC	Common Stock		D						605
2013-11-07		3	Sanofi Via wholly-owned subsidiary, Genzyme Corp.	GLYC	Preferred Stock		I						1,193,625

Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.

Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.

Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)

Konversi turunan

Penjualan atau pengalihan sekuritas kembali ke perusahaan.

Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.

Pemberian sekuritas oleh atau kepada orang dalam.

Swap ekuitas dan transaksi lindung nilai serupa

Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)

Transaksi yang dilaporkan secara sukarela pada Formulir 4.

Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)

GLYC / GlycoMimetics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5